# Teclistamab in Previously Treated AL Amyloidosis

> **NCT06935162** · PHASE2 · RECRUITING · sponsor: **Peking Union Medical College Hospital** · enrollment: 30 (estimated)

## Conditions studied

- AL Amyloidosis

## Interventions

- **DRUG:** Teclistamab (Tec)

## Key facts

- **NCT ID:** NCT06935162
- **Lead sponsor:** Peking Union Medical College Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-05-21
- **Primary completion:** 2026-12-31
- **Final completion:** 2028-12-31
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2025-05-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06935162

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06935162, "Teclistamab in Previously Treated AL Amyloidosis". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT06935162. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*